[HTML][HTML] Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations
Abstract The World Federation for Ultrasound in Medicine and Biology has produced these
guidelines for the use of elastography techniques in liver diseases. For each available …
guidelines for the use of elastography techniques in liver diseases. For each available …
Hepatic microcirculation and mechanisms of portal hypertension
J Gracia-Sancho, G Marrone… - Nature reviews …, 2019 - nature.com
The liver microcirculatory milieu, mainly composed of liver sinusoidal endothelial cells
(LSECs), hepatic stellate cells (HSCs) and hepatic macrophages, has an essential role in …
(LSECs), hepatic stellate cells (HSCs) and hepatic macrophages, has an essential role in …
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo …
C Villanueva, A Albillos, J Genescà, JC Garcia-Pagan… - The lancet, 2019 - thelancet.com
Background Clinical decompensation of cirrhosis is associated with poor prognosis.
Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure …
Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure …
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …
followed by a decompensated phase, marked by the development of overt clinical signs, the …
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of …
J Neuberger, J Patel, H Caldwell, S Davies, V Hebditch… - Gut, 2020 - gut.bmj.com
Liver biopsy is required when clinically important information about the diagnosis, prognosis
or management of a patient cannot be obtained by safer means, or for research purposes …
or management of a patient cannot be obtained by safer means, or for research purposes …
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek… - Hepatology, 2018 - journals.lww.com
Emerging studies have suggested that the Hippo pathway is involved in the tumorigenesis of
hepatocellular carcinoma (HCC). However, the key regulator of the Hippo pathway in liver …
hepatocellular carcinoma (HCC). However, the key regulator of the Hippo pathway in liver …
[HTML][HTML] HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
Background & Aims Hepatocellular carcinoma (HCC) is a major cause of morbidity and
mortality in patients with advanced chronic liver disease (ACLD) caused by chronic hepatitis …
mortality in patients with advanced chronic liver disease (ACLD) caused by chronic hepatitis …
Fibrosis regression after eradication of hepatitis C virus: from bench to bedside
DC Rockey, SL Friedman - Gastroenterology, 2021 - Elsevier
Hepatitis C virus (HCV) infection and its complications have been the major cause of
cirrhosis and its complications for several decades in the Western world. Until recently …
cirrhosis and its complications for several decades in the Western world. Until recently …
[HTML][HTML] Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
LAP Krassenburg, R Maan, A Ramji, MP Manns… - Journal of …, 2021 - Elsevier
Background & Aims HCV-infected patients with cirrhosis achieve high sustained virological
response (SVR) rates with direct-acting antivirals (DAAs) even after hepatic …
response (SVR) rates with direct-acting antivirals (DAAs) even after hepatic …